Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TFAP2C is a key regulator of intrauterine trophoblast cell invasion and deep hemochorial placentation
Esteban M. Dominguez, Ayelen Moreno-Irusta, Regan L. Scott, Khursheed Iqbal, Michael J. Soares
Esteban M. Dominguez, Ayelen Moreno-Irusta, Regan L. Scott, Khursheed Iqbal, Michael J. Soares
View: Text | PDF
Research Article Development Reproductive biology

TFAP2C is a key regulator of intrauterine trophoblast cell invasion and deep hemochorial placentation

  • Text
  • PDF
Abstract

Transcription factor AP-2 gamma (TFAP2C) has been identified as a key regulator of the trophoblast cell lineage and hemochorial placentation. The rat possesses deep placentation characterized by extensive intrauterine trophoblast cell invasion, which resembles human placentation. Tfap2c is expressed in multiple trophoblast cell lineages, including invasive trophoblast cells situated within the uterine-placental interface of the rat placentation site. Global genome editing was used to explore the biology of Tfap2c in rat placenta development. Homozygous global disruption of Tfap2c resulted in prenatal lethality. Heterozygous global disruption of Tfap2c was associated with diminished invasive trophoblast cell infiltration into the uterus. The role of TFAP2C in the invasive trophoblast cell lineage was explored using Cre-lox conditional mutagenesis. Invasive trophoblast cell–specific disruption of Tfap2c resulted in inhibition of intrauterine trophoblast cell invasion and intrauterine and postnatal growth restriction. The invasive trophoblast cell lineage was not impaired following conditional monoallelic disruption of Tfap2c. In summary, TFAP2C contributes to the progression of distinct stages of placental development. TFAP2C is a driver of early events in trophoblast cell development and reappears later in gestation as an essential regulator of the invasive trophoblast cell lineage. A subset of TFAP2C actions on trophoblast cells are dependent on gene dosage.

Authors

Esteban M. Dominguez, Ayelen Moreno-Irusta, Regan L. Scott, Khursheed Iqbal, Michael J. Soares

×

Figure 2

Tfap2c gene dosage effects on placental development.

Options: View larger image (or click on image) Download as PowerPoint

Tfap2c gene dosage effects on placental development.
Placentation sites...
Placentation sites were generated from Tfap2c+/– male and Tfap2c+/+ female breeding. (A) Identification of placentation site compartments Tfap2c+/+ and Tfap2c+/– using vimentin immunostaining (magenta). (B) Immunohistochemical localization of cytokeratin protein in gestation day (gd) 18.5 Tfap2c+/+ and Tfap2c+/– placentation sites (cyan). (C) Distribution of Prl7b1 transcripts in gd 18.5 Tfap2c+/+ and Tfap2c+/– placentation sites (yellow). (D) Quantification of trophoblast cell invasion area (magenta dotted line in B) determined by cytokeratin immunostaining within the uterine-placental interface. Data are expressed as mean ± standard error of the mean (SEM). Each data point represents different uterine-placental interface tissues (n = 4) obtained from 4 pregnancies. (E) Reverse transcription quantitative PCR (RT-qPCR) of invasive trophoblast cell–specific transcripts in gd 18.5 Tfap2c+/+ and Tfap2c+/– uterine-placental interface tissues. Data are expressed as mean ± SEM. Each data point represents a biological replicate obtained from 6 pregnancies (n = 6). (F) Fetal, placenta, junctional zone, and labyrinth zone weights for gd 18.5 Tfap2c+/+ and Tfap2c+/– conceptuses. Data are expressed as mean ± SEM. Each data point represents a biological replicate obtained from 6 pregnancies (Tfap2c+/+, n = 38; Tfap2c+/–, n = 32). Scale bars: 500 μm. Unpaired t test: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. UPI, uterine-placental interface; JZ, junctional zone; LZ, labyrinth zone; SpA, spiral artery.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts